Study to Assess the Safety, Tolerability, and Pharmacokinetics of REGN5381 (an NPR1 Agonist) in Adult Humans

计划入组 90 人 · 首次发布于 2020 年 8 月 10 日

Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

计划入组 82 人 · 首次发布于 2024 年 9 月 19 日

A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension

计划入组 76 人 · 首次发布于 2024 年 9 月 23 日

SPR1

NPRD-003

NPRD-002

Regeneron Advances Two Major Clinical Programs in Critical Care and Cardiovascular Disease

Regeneron Advances REGN9533 Blood Clot Treatment Through Phase 1 While Terminating Heart Failure Program

Self-Amplifying RNA Therapy Shows Promise for Heart Attack Recovery in Preclinical Studies